Regulatory & Compliance

Regulatory shifts are forcing health service providers to move away from passive privacy policies toward active notification systems, such as website pop-ups, that inform users of data collection at the point of entry. This transition comes at a critical juncture where the boundary between seeking

Although 75 percent of the public believes weight-loss drugs are used for cosmetic reasons, 66 percent still find their use to be socially acceptable in modern society. This fundamental shift in perception coincides with the rise of glucagon-like peptide-1 receptor agonists, which have

The move away from carbon offsetting signals a maturation in corporate sustainability where physical decarbonization takes precedence over accounting-based neutrality claims. This evolution reflects a growing understanding that the pharmaceutical industry must confront its environmental impact

Between March 2020 and April 2023, invisible tracking pixels embedded on the LifeStance Health website harvested sensitive information from more than one million prospective patients. This legal resolution comes as a response to allegations that the company improperly shared sensitive patient

Preliminary research indicates that artificial intelligence can identify documented medical implants within electronic health records with an accuracy rate exceeding eighty percent. This development comes at a critical juncture in radiology, as the historical precedent of flatly denying magnetic

The shift toward human-first data collection aims to prevent the loss of hundreds of millions of dollars caused by unforeseen safety issues in clinical trials. For decades, the pharmaceutical industry relied almost exclusively on animal models, yet nearly ninety percent of drugs that pass animal